BioCardia, Inc. (BCDA)
NASDAQ: BCDA · IEX Real-Time Price · USD
0.368
+0.008 (2.17%)
At close: Apr 22, 2024, 4:00 PM
0.356
-0.012 (-3.32%)
After-hours: Apr 22, 2024, 7:59 PM EDT

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $9.88 million. The enterprise value is $10.09 million.

Market Cap 9.88M
Enterprise Value 10.09M

Important Dates

The next estimated earnings date is Wednesday, May 8, 2024, after market close.

Earnings Date May 8, 2024
Ex-Dividend Date n/a

Share Statistics

BioCardia has 26.87 million shares outstanding. The number of shares has increased by 19.52% in one year.

Shares Outstanding 26.87M
Shares Change (YoY) +19.52%
Shares Change (QoQ) +4.21%
Owned by Insiders (%) 33.84%
Owned by Institutions (%) 7.71%
Float 17.60M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 20.72
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 21.16
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio 0.41
Quick Ratio 0.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -3,638.70%.

Return on Equity (ROE) -3,638.70%
Return on Assets (ROA) -228.60%
Return on Capital (ROIC) n/a
Revenue Per Employee $29,813
Profits Per Employee -$723,188
Employee Count 16
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.79% in the last 52 weeks. The beta is 1.49, so BioCardia's price volatility has been higher than the market average.

Beta (1Y) 1.49
52-Week Price Change -81.79%
50-Day Moving Average 0.42
200-Day Moving Average 0.66
Relative Strength Index (RSI) 40.77
Average Volume (30 Days) 358,074

Short Selling Information

The latest short interest is 535,913, so 1.99% of the outstanding shares have been sold short.

Short Interest 535,913
Short Previous Month 1.01M
Short % of Shares Out 1.99%
Short % of Float 3.04%
Short Ratio (days to cover) 0.83

Income Statement

In the last 12 months, BioCardia had revenue of $477,000 and -$11.57 million in losses. Loss per share was -$0.55.

Revenue 477,000
Gross Profit 477,000
Operating Income -11.64M
Pretax Income -11.57M
Net Income -11.57M
EBITDA -11.16M
EBIT -11.57M
Loss Per Share -$0.55
Full Income Statement

Balance Sheet

The company has $1.10 million in cash and $1.32 million in debt, giving a net cash position of -$212,000 or -$0.01 per share.

Cash & Cash Equivalents 1.10M
Total Debt 1.32M
Net Cash -212,000
Net Cash Per Share -$0.01
Equity / Book Value -1.60M
Book Value Per Share -0.06
Working Capital -2.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.97 million and capital expenditures -$12,000, giving a free cash flow of -$9.99 million.

Operating Cash Flow -9.97M
Capital Expenditures -12,000
Free Cash Flow -9.99M
FCF Per Share -$0.47
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,441.09% and -2,425.79%.

Gross Margin 100.00%
Operating Margin -2,441.09%
Pretax Margin -2,425.79%
Profit Margin -2,425.79%
EBITDA Margin -2,339.62%
EBIT Margin -2,425.79%
FCF Margin -2,093.50%

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -19.52%
Shareholder Yield -19.52%
Earnings Yield -117.09%
FCF Yield -101.05%

Analyst Forecast

The average price target for BioCardia is $4.00, which is 987.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.00
Price Target Difference 987.55%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 161.70%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.

Last Split Date Jun 6, 2019
Split Type Reverse
Split Ratio 1:9

Scores

BioCardia has an Altman Z-Score of -83.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -83.52
Piotroski F-Score 2